Healthcare & Existence Sciences Private Equity Finance Deal Tracker: Warburg Pincus to take a position as much as $300 Million in Vertice Pharma
PE firm Warburg Pincus has announced it’ll invest as much as $300 million in new pharmaceutical company Vertice Pharma.
Vertice Pharma, that has its U.S. headquarters in Nj, will concentrate on obtaining niche pharmaceutical companies and merchandise. It had been launched by pharmaceutical industry veterans Don DeGolyer and Andrew Saik together with Warburg Pincus.
Vertice Parma’s first acquisition is VistaPharm, a Birmingham, Ala.-based specialized generics manufacturer of liquid and unit dosage discomfort medications for that hospital market, retail pharmacy and outpatient clinics.
Warburg Pincus, headquartered in New You are able to, began in 1966. The firm focuses mainly on purchasing healthcare and consumer products technology, media and telecommunications financial services energy and industrial and business services. It’s invested greater than $50 billion in additional than 720 companies situated in greater than 35 countries.